Clearance Summary
EDIA ANTI-CCP received FDA 510(k) clearance under submission number K062045, sponsored by Euro-Diagnostica AB. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2006-12-04.
- Submission: K062045
- Applicant / Sponsor: Euro-Diagnostica AB
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5775
- Decision date: 2006-12-04
Classification & Regulation
This clearance is catalogued under FDA product code NHX and 21 CFR 866.5775, within the Immunology review panel as a Class II device.